NUCLEIC ACIDS RES 润色咨询

NUCLEIC ACIDS RESEARCH

出版年份:暂无数据 年文章数:18992 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:7.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2021-05-24 北大科研初学者

    审稿速度:1.0 | 投稿命中率:5.0
    偏重的研究方向:机制明确;癌症;生物信息学
    经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2020-10-23 斯人逸趣

    主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2020-09-21 bin.liu_23318428

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2020-04-21 ms3212165295344000

    国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!
    各位大佬都不好管灌水的杂志 分了一区有什么用?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2020-03-08 王者之父

    期待有个好结果

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2020-03-06 ms3860263520721591

    审稿速度:3.0
    经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?
    plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。
    nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?
    中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区
    当今学者言论文必称几区几区 有谁还管文章质量?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2019-10-25 ms1387158037523886

    效率超高,第一天投,第二天拒

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2019-10-12 ms7260643641707155

    21-aug-2019:投稿;
    11-sep-2019:三个审稿人意见positive,in principle accepted;
    10-oct-2019:提交回复审稿人意见,附内容修改版本;
    11-oct-2019:文章接收。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-12 小莫武

    您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢段段53228 2017-10-19 15:08:00 发表:
    小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的

    段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=968269, encodeId=cb2d968269dc, content=审稿速度:1.0 | 投稿命中率:5.0<br>偏重的研究方向:机制明确;癌症;生物信息学<br>经验分享:至少我们癌症领域很难发,送审率不足10%!之前我们投稿3篇,只送审一篇,有幸中了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90b25397444, createdName=北大科研初学者, createdTime=Mon May 24 22:41:24 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893938, encodeId=2b848939386c, content=主要生物信息学高引用维持高IF,本质上与JBC一样经典杂志,但比PNAS, EMBO J, JCB, current Biology稍差。过去的投稿都是先NCS,再PNAS,再JBC or NAR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53215428458, createdName=斯人逸趣, createdTime=Fri Oct 23 13:15:10 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887028, encodeId=82f888e0288a, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:NAR是经典老牌杂志,文章水平很高,花里胡哨的工作不多。水平应该跟PNAS, NC相当,甚至略强。中科院分区真的是太扯淡了。这个杂志的分应该还是要涨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81d52459754, createdName=bin.liu_23318428, createdTime=Mon Sep 21 09:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=859687, encodeId=c65485968e4f, content=国内人好灌水的必须都到一区可 不好灌水的禁止进入一区!<br> 各位大佬都不好管灌水的杂志 分了一区有什么用? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Tue Apr 21 23:17:23 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586153, encodeId=5ec558615372, content=期待有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/15/4b2ed48c3a00c0aa677528e43a7b6cf2.jpg, createdBy=bb2f1949060, createdName=王者之父, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858086, encodeId=071385808609, content=审稿速度:3.0<br>经验分享:新加的这个分区吧nar分在二区 这是有病吧? 仔细读读这一两年nar的文章(排除数据库和软件)。根本不会比embo j 还有 pnas 差。 我估计是中科院这帮人nar的文章大部分都不懂吧?<br> plant physiology 倒是分到了一区。 一个做植物的如果能发到nar会有人投plant physiology? plant cell 估计如今也没法和nar pk了吧。<br> nar 发了大量冷门文章,还能维持11分的点数,水平能查到2区?<br> 中科院期刊分区就是只看杂志不看文脏内容的最大推手。中国要想彻底摆脱唯sci是从的局面必须先破除中科院分区<br> 当今学者言论文必称几区几区 有谁还管文章质量? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Fri Mar 06 03:14:19 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854504, encodeId=239a854504d1, content=效率超高,第一天投,第二天拒 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=454b5414145, createdName=ms1387158037523886, createdTime=Fri Oct 25 23:07:31 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854214, encodeId=2776854214af, content=21-aug-2019:投稿;<br> 11-sep-2019:三个审稿人意见positive,in principle accepted;<br> 10-oct-2019:提交回复审稿人意见,附内容修改版本;<br> 11-oct-2019:文章接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed55413980, createdName=ms7260643641707155, createdTime=Sat Oct 12 09:33:11 CST 2019, time=2019-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560039, encodeId=5b4b56003988, content=您好,我在准备投稿,请问您有nucleic acids research的投稿word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">段段53228 2017-10-19 15:08:00 发表:<br>小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的</span>, beContent=段段53228 2017-10-19 15:08:00 发表: 小白上来请教大家一个问题,这个杂志分很多版块,这个是在投稿的时候要选吗,还是后期人家编辑自己整理的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560038, encodeId=edf45600383b, content=请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢<span class="quote">152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:<br>3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受</span>, beContent=152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItsCmicHzCoTGHNuPSdK8ykUpNkxYic9sz046FicIriaOW0PVEND7UPcQBcsukWyIED3ibkrnHGDpgLhQ/132, createdBy=595c2417774, createdName=小莫武, createdTime=Sun Aug 12 00:00:00 CST 2018, time=2018-08-12, status=1, ipAttribution=)]
    2018-08-12 小莫武

    请问您有NAR的word模板吗?我写的被说模板不对,您看是否方便聊一下,十分感谢152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表:
    3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受

    152kAaJ0823(暂无昵称) 2018-05-06 00:00:00 发表: 3月24日 提交 两周后需要小改 重写了abstract 5月1号 接受

    0

共111条页码: 3/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分